• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6诱导的病理学

Pathology induced by interleukin-6.

作者信息

Ryffel B, Mihatsch M J, Woerly G

机构信息

Institut für Toxikologie, Eidgenössischen Technischen Hochschule Universität Zürich, Switzerland.

出版信息

Int Rev Exp Pathol. 1993;34 Pt A:79-89.

PMID:8454418
Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine that plays an important role in the immune response, hemopoiesis, and host defense. Recombinant human IL-6 (rhIL-6) was administered at high doses to mice, rats, and nonhuman primates. In all species, IL-6 had an immunostimulatory and hemopoietic (especially on megakaryocytes) effect. An acute-phase response was most pronounced in nonhuman primates, which was, however, not associated with any significant histopathological liver change. Finally, no evidence of glomerular pathology was found. Neutralizing antibodies were detected within 10 days of rhIL-6 administration in all species.

摘要

白细胞介素-6(IL-6)是一种多功能细胞因子,在免疫反应、造血和宿主防御中发挥重要作用。已将重组人IL-6(rhIL-6)以高剂量给予小鼠、大鼠和非人类灵长类动物。在所有物种中,IL-6均具有免疫刺激和造血(尤其是对巨核细胞)作用。急性期反应在非人类灵长类动物中最为明显,然而,这与任何明显的肝脏组织病理学变化均无关。最后,未发现肾小球病变的证据。在所有物种中,rhIL-6给药后10天内均检测到中和抗体。

相似文献

1
Pathology induced by interleukin-6.白细胞介素-6诱导的病理学
Int Rev Exp Pathol. 1993;34 Pt A:79-89.
2
Pathology induced by interleukin-6.白细胞介素-6诱导的病理学
Toxicol Lett. 1992 Dec;64-65 Spec No:311-9. doi: 10.1016/0378-4274(92)90203-v.
3
Continuous administration of Il-13 to mice induces extramedullary hemopoiesis and monocytosis.持续给小鼠注射白细胞介素-13会诱导髓外造血和单核细胞增多。
J Immunol. 1996 May 1;156(9):3166-73.
4
Thrombopoietic effects of interleukin-6 in long-term administration in mice.白细胞介素-6在小鼠长期给药中的促血小板生成作用。
Exp Hematol. 1993 May;21(5):640-6.
5
Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.在小鼠中持续皮下输注重组人白细胞介素-11:高效递送增强生物活性。
Exp Hematol. 1996 Feb;24(2):270-6.
6
Subcutaneous or oral administration of rhIL-11 modulated the contact hypersensitivity response.皮下或口服重组人白细胞介素-11可调节接触性超敏反应。
Cytokine. 2000 Dec;12(12):1769-77. doi: 10.1006/cyto.2000.0792.
7
Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.白细胞介素-6可保护肝脏免受热缺血/再灌注损伤,并促进啮齿动物肝细胞增殖。
Hepatology. 1997 Dec;26(6):1513-20. doi: 10.1002/hep.510260619.
8
Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.转移性肾细胞癌或恶性黑色素瘤患者每周两次静脉注射白细胞介素12的I期试验:维持γ干扰素诱导的能力与临床反应相关。
Clin Cancer Res. 2000 May;6(5):1678-92.
9
Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse.白细胞介素1受体拮抗剂抑制正常造血,并降低小鼠5-氟尿嘧啶的致死率和骨髓毒性。
Biomed Pharmacother. 2009 Aug;63(7):501-8. doi: 10.1016/j.biopha.2008.09.014. Epub 2008 Oct 23.
10
Potential use of recombinant human interleukin-6 in clinical oncology.重组人白细胞介素-6在临床肿瘤学中的潜在应用。
Leuk Lymphoma. 1996 Feb;20(5-6):373-9. doi: 10.3109/10428199609052418.

引用本文的文献

1
Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.给药方案对小鼠α干扰素药代动力学及抗α干扰素中和抗体的影响。
Antimicrob Agents Chemother. 2001 Jan;45(1):176-80. doi: 10.1128/AAC.45.1.176-180.2001.
2
Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.大鼠T9胶质瘤克隆的白细胞介素-6转导导致致瘤性减弱,并在Fischer F344大鼠中诱导胶质瘤免疫。
J Neurooncol. 1999;45(3):209-18. doi: 10.1023/a:1006357424124.
3
Effects of recombinant human interleukin 6 (rhIL-6) in marmosets (Callithrix jacchus). 1. General toxicity and hematological changes.
Arch Toxicol. 1994;68(10):619-31. doi: 10.1007/BF03208341.